Skip to Primary Navigation

Skip to main content

Report to US lawmakers flags impact of China pharma on US drug supply chain

CHONGQING, CHINA - OCTOBER 7: A woman walks past rows of Chinese national flags displayed at the square in front of the Chongqing People's Auditorium during the National Day Golden Week holiday on October 7, 2025, in Chongqing, China. Streets and public squares across the country are decorated with national flags to celebrate the founding of the People's Republic of China.
Photo: Cheng Xin/Getty Images

Kevin Kinsella

2 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

The report urges Congress to bolster US pharmaceutical supply-chain resilience and reduce dependence on China.

A new report from the bipartisan US-China Economic and Security Review Commission is urging Congressional lawmakers not to ignore the impact of China’s growing influence on US drug development. It underscored that if the United States doesn’t respond quickly, there could be serious concerns for the domestic supply chain.

, , , , , , ,